Annals of Oncology, 0923-7534

Journal

1 - 10 out of 41Page size: 10

Publications

  1. Published

    Breast cancer index and prediction of benefit from extended endocrine therapy in breast cancer patients treated in the Adjuvant Tamoxifen—to offer more? (aTTom) trial

    Ikhlaaq Ahmed, Sarah Pirrie & Daniel Rea, Nov 2019, In: Annals of Oncology. 30, 11, p. 1776-1783 8 p.

    Research output: Contribution to journal › Article › peer-review

  2. Published

    A randomised multicentre trial of modified CHOP versus MCOP in patients aged 65 years and over with aggressive non-Hodgkin's lymphoma (NHL)

    Burton Marshall & Lynn Jones, 1 Feb 2003, In: Annals of Oncology. 14, 2, p. 258-267 10 p.

    Research output: Contribution to journal › Article

  3. Published

    Targeting angiogenesis with monoclonal antibodies.

    Roy Bicknell, 1 Sep 2006, In: Annals of Oncology. 17 Suppl 10, p. x76-8

    Research output: Contribution to journal › Article

  4. Published

    The benefits of chemotherapy in patient subgroups with unresectable non-small-cell lung cancer

    Lucinda Billingham, 1 Jan 2001, In: Annals of Oncology. 12, 12, p. 1671-1675 5 p.

    Research output: Contribution to journal › Article

  5. Published

    Paediatric lymphoproliferative disease: UKCCSG 9494 study of prognostic variables and outcome

    1 Jan 2002, In: Annals of Oncology. 13, p. 13 1 p.

    Research output: Contribution to journal › Article

  6. Published

    Neoadjuvant vinorelbine/epirubicin (VE) versus standard adriamycin/ cyclophosphamide (AC) in operable breast cancer: Analysis of response and tolerability in a randomised phase III trial (TOPIC 2)

    & 22 others, , Timothy Howell & Daniel Rea, 1 Sep 2005, In: Annals of Oncology. 16, 9, p. 1435-1441 7 p.

    Research output: Contribution to journal › Article › peer-review

  7. Published

    Questioning specialists’ attitudes to breast cancer follow-up in primary care

    Sarah Bathers, 1 Sep 2007, In: Annals of Oncology. 18, 9, p. 1467-1476 10 p.

    Research output: Contribution to journal › Article

  8. Published

    Disease-free and overall survival at 3.5 years for neoadjuvant bevacizumab added to docetaxel followed by fluorouracil, epirubicin and cyclophosphamide, for women with HER2 negative early breast cancer: ARTemis Trial

    Daniel Rea & 1 others, , 27 Apr 2017, In: Annals of Oncology.

    Research output: Contribution to journal › Article › peer-review

  9. Published

    Palliative care in hospital, hospice, at home: results from a systematic review

    31 Dec 2002, In: Annals of Oncology. 13, p. 257-264 8 p.

    Research output: Contribution to journal › Article

  10. Published

    The effect of Epstein-Barr virus status on survival in age and sex defined subgroups of patients with advanced Hodgkin's disease

    Lucinda Billingham, Joanne Gough, Lawrence Young & Paul Murray, 1 Feb 2003, In: Annals of Oncology. 14, 2, p. 282-290 9 p.

    Research output: Contribution to journal › Article

Previous 1 2 3 4 5 Next